AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids

    NEXT STORY
    Femtech Market value to cross $48.5 billion by 2025: Global Market Insights, Inc.
    PREV STORY
    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medtronic Pledges Support to End Obesity Stigma

    author_avatar
    NASDAQ Market News

    CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

    OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the ...

    author_avatar
    NASDAQ Market News

    Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study

    IRVINE, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer ...

    author_avatar
    NASDAQ Market News